QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,847 signal articles · 515 in last 24h · 105,930 total before filter · latest 1h ago
515last 24h
2480last 7d
488● bullish (7d)
253● bearish (7d)
200publishers
AllMacro166Earnings1541M&A143Regulatory15Product8Analyst23
✕ clear all filterssentiment: bearishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
CAT Stock Downgrade On Data Center Moratorium Hamstrings Dow Jones Industrial Futures
Investor's Business Daily8d agobearish
CAT Stock Downgrade On Data Center Moratorium Hamstrings Dow Jones Industrial Futures

Caterpillar's strong order and backlog growth are likely to slow in 2027 and 2028, Baird projected on Wednesday, highlighting the recent New York data center moratorium as an example of growing state and local regulatory pushback. CAT stock dragged the Dow Jones into the red before Wednesday's open, as S&P 500 futures pointed higher. Baird downgraded CAT to neutral from outperform, cutting its price target to 900 from 1,200, according to The Fly investment news site.

Bloomberg8d agobearish
The High-School Dropout Hiring Diplomats for Trump’s State Department

(Bloomberg) -- Andrew Crapuchettes, the founder of a boutique Idaho firm that specializes in headhunting conservative employees, was surfing LinkedIn when an unsolicited message appeared from an unlikely employer: the US State Department.Most Read from BloombergUS Intercepts Iran Attack on Bases, Puncturing Days of CalmSK Hynix Profit Disappoints, Spending Soars to $31 BillionApple Set to Make Big Smart Home Push With Siri AI at CenterNvidia’s $750 Billion in Deals Reignite Circular AI FearsChip

Procter & Gamble (NYSE:PG) Misses Q2 CY2026 Revenue Estimates
StockStory8d agobearish
Procter & Gamble (NYSE:PG) Misses Q2 CY2026 Revenue Estimates

Consumer products behemoth Procter & Gamble (NYSE:PG) missed Wall Street’s revenue expectations in Q2 CY2026 as sales only rose 1.5% year on year to $21.2 billion. Its non-GAAP profit of $1.43 per share was 1.6% above analysts’ consensus estimates.

Boston Scientific (NYSE:BSX) Surprises With Q2 CY2026 Sales But Quarterly Revenue Guidance Misses Expectations
StockStory8d agobearish
Boston Scientific (NYSE:BSX) Surprises With Q2 CY2026 Sales But Quarterly Revenue Guidance Misses Expectations

Medical device company Boston Scientific (NYSE:BSX) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 7.5% year on year to $5.44 billion. On the other hand, next quarter’s revenue guidance of $5.27 billion was less impressive, coming in 2.2% below analysts’ estimates. Its non-GAAP profit of $0.86 per share was 3.8% above analysts’ consensus estimates.

SK Hynix Shares Slide Despite Record Profit as Results Miss Lofty Expectations
InvestorsHub8d agobearish
SK Hynix Shares Slide Despite Record Profit as Results Miss Lofty Expectations

SK Hynix (NASDAQ:SKHY) reported record quarterly earnings on Wednesday, but its shares tumbled nearly 10% after the results fell short of elevated market expectations, fuelling concerns that spending on artificial intelligence infrastructure by major technology companies could begin to slow. The South Korean memory chip maker, a key supplier to Nvidia, is also pursuing more long-term supply agreements as it looks to reduce exposure to the semiconductor industry’s cyclical demand swings.

Generac (NYSE:GNRC) Misses Q2 CY2026 Sales Expectations
StockStory8d agobearish
Generac (NYSE:GNRC) Misses Q2 CY2026 Sales Expectations

Power generation products company Generac (NYSE:GNRC) fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 10.6% year on year to $1.17 billion. Its non-GAAP profit of $2.91 per share was 44.6% above analysts’ consensus estimates.

Teladoc Health (TDOC) Stock Still Looks Undervalued After a 94% Five Year Fall
Simply Wall St.8d agobearish
Teladoc Health (TDOC) Stock Still Looks Undervalued After a 94% Five Year Fall

Teladoc Health stock is coming off a very steep 5 year decline. Current checks suggest the shares may now be trading below a reasonable estimate of intrinsic value, with both the Discounted Cash Flow (DCF) work and market based multiples pointing to upside at the recent US$9.36 close. Teladoc Health shareholders have seen the stock fall 93.8% over the past 5 years, which means any current valuation gap matters a lot for investors who are reassessing the long term case. The planned Teladoc...

Vertiv (NYSE:VRT) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops 10.4%
StockStory8d agobearish
Vertiv (NYSE:VRT) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops 10.4%

Data center products and services company Vertiv (NYSE:VRT) fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 24.1% year on year to $3.27 billion. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $3.75 billion at the midpoint, or 0.9% above analysts’ estimates. Its non-GAAP profit of $1.52 per share was 6.4% above analysts’ consensus estimates.

Bloomberg8d agobearish
AI Boom Spurs Insider Selling by Nvidia, CoreWeave Billionaires

(Bloomberg) -- Executives and investors tied to the AI supply chain were among the biggest insider sellers in the second quarter, taking advantage of a sharp — and volatile — rally in technology stocks.Most Read from BloombergUS Intercepts Iran Attack on Bases, Puncturing Days of CalmSK Hynix Profit Disappoints, Spending Soars to $31 BillionNvidia’s $750 Billion in Deals Reignite Circular AI FearsChip Rout Deepens on Circular Funding, China Competition FearsApple Set to Make Big Smart Home Push